CD279, Human (Pembrolizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-CD279, Human (Pembrolizumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCD279, Human (Pembrolizumab biosimilar)
ClonePembrolizumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG4 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
Applicationsn/a
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human CD279 Recombinant Antibody (Pembrolizumab). Pembrolizumab, sold under the brand name Keytruda, is a humanized antibody used in cancer immunotherapy that treats melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, and stomach cancer. It is given by slow injection into a vein.
Immunogenn/a
Other NamesAnti-CD279 Recombinant Antibody, Research Grade Pembrolizumab, Anti-Human CD279 Recombinant Antibody(Pembrolizumab), MK-3475, Antibody Drug Analogues, Monoclonal Antibody, YR1012, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 1374853-91-4
Catalog #YR1012
Priceplease inquire
Order / More InfoCD279, Human (Pembrolizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.